Chantkran, Wittawat http://orcid.org/0000-0001-7877-0222
Hsieh, Ya-Ching
Zheleva, Daniella
Frame, Sheelagh
Wheadon, Helen
Copland, Mhairi http://orcid.org/0000-0002-7655-016X
Article History
Received: 10 February 2021
Revised: 4 April 2021
Accepted: 22 April 2021
First Online: 10 June 2021
Change Date: 6 July 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41420-021-00558-1
Conflict of interest
: M.C.: research funding (Cyclacel Ltd, Novartis, BMS, Incyte), advisory board member (BMS, Novartis, Incyte, Pfizer, Daiichi Sankyo), and honoraria (Astellas, BMS, Novartis, Incyte, Pfizer, Takeda, Celgene). D.Z. and S.F. are employees of Cyclacel Ltd. The remaining authors declare no competing interests.
: Healthy donor and diagnostic primary AML samples were taken in accordance with the Declaration of Helsinki, and Ethics Committee approval (15/WS/0077).